Government

By Christopher Ivicevich, Director of Regulatory Affairs & Quality Compliance, OptraSCAN With the recent shift in the industry as the result of this decision, a common question is “What lies in store for digital pathology system...

Promega Corporation intends to seek FDA approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. The current Promega...

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS)...

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM - 11:00 AM EDT Register Asia & Europe: 3:00 PM - 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now...

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...

This past Memorial Day weekend I gave a lot of thought to those who have passed defending our freedoms and way of life as well as those who have served and survived to be cared for by our society. About 3 years ago stories began to break about...